You are here: Industry Insights > TBI

News List

Vectura, Incannex Enter Preclinical Services Agreement contractpharma
June 23, 2021
Vectura to provide development services for IHL-216A, Incannex’s inhaled drug product for the treatment of traumatic brain injury.
Mortality Increased for Racial/Ethnic Minorities With TBI drugs
June 09, 2021
For patients with traumatic brain injury, racial and ethnic minorities have an increased risk for mortality, according to a study published online June 2 in Frontiers in Surgery.
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery prnasia
April 15, 2021
Moleac, a biopharmaceutical company based in Singapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI).
Abbott Receives FDA 510(k) Clearance for Rapid Handheld Blood Test for Concussions americanpharmaceuticalreview
January 15, 2021
Abbott has received 510(k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions.
Tony Blair Institute and Oracle Launch Africa Vaccine Management in the Cloud prnasia
November 24, 2020
The Tony Blair Institute (TBI) and Oracle have brought cloud technology to Africa to manage public health programs. Initially, Ghana, Rwanda, and Sierra Leone will use the new Oracle Health Management System to create electronic health records for ...
Antipsychotic Initiation Ups Risk for Head Injury, TBI in Alzheimer Disease drugs
January 20, 2020
Individuals with Alzheimer disease (AD) initiating antipsychotics have an increased risk for head injuries and traumatic brain injury (TBI), according to a study published online January in the Journal of the American Geriatrics Society.
Vets With Traumatic Brain Injury Have Higher Suicide Risk drugs
September 12, 2019
The risk of suicide among U.S. military veterans who have suffered a traumatic brain injury (TBI) is more than double that of other vets, a new study finds.
NeurAegis Scientific Founder Awarded Grant to Advance Traumatic Brain Injury Treatment americanpharmaceuticalreview
September 06, 2019
NeurAegis announced its scientific founder, Dr. Michel Baudry, has been awarded a multi-year, $3.8 million grant from the Department of Defense's Combat Casualty Care Research Program.
Plasma Marker May Help Detect Traumatic Brain Injury drugs
August 30, 2019
Plasma concentration of glial fibrillary acidic protein (GFAP) can aid in detecting traumatic brain injury (TBI) by identifying patients with negative findings on computed tomography (CT) scan...
Functional Limitations Persist One Year After Mild TBI drugs
June 04, 2019
Functional Limitations Persist One Year After Mild TBI.

Previous page 1 2 Next page